Janet Hurt

Ms. Hurt joined Jasper Therapeutics as Vice President of Clinical Operations in 2020. In this position, she is responsible for the leadership, strategic planning, oversight and execution of clinical programs. She has nearly 30 years of clinical trial experience. Most recently, she served as Vice President of Clinical Operations at Denali Therapeutics where she built the Clinical Operations function, which included Clinical Data Management and Clinical Outsourcing. She and her team were accountable for all activities related to execution and management of clinical studies and programs. Prior to that, she led Clinical Operations at Bavarian Nordic, XenoPort, Perlegen Sciences and Amgen. Ms. Hurt earned an M.P.H. and a B.S. from San Jose State University.